How the ER-associated degradation (ERAD) machinery accurately identifies terminally misfolded proteins is poorly understood. For luminal ERAD substrates, this recognition depends on their folding and glycosylation status as well as on the conserved ER lectin Yos9p. Here we show that Yos9p is part of a stable complex that organizes key components of ERAD machinery on both sides of the ER membrane, including the transmembrane ubiquitin ligase Hrd1p. We further demonstrate that Yos9p, together with Kar2p and Hrd3p, forms a luminal surveillance complex that both recruits nonnative proteins to the core ERAD machinery and assists a distinct sugar-dependent step necessary to commit substrates for degradation. When Hrd1p is uncoupled from the Yos9p surveillance complex, degradation can occur independently of the requirement for glycosylation. Thus, Yos9p/Kar2p/Hrd3p acts as a gatekeeper, ensuring correct identification of terminally misfolded proteins by recruiting misfolded forms to the ERAD machinery, contributing to the interrogation of substrate sugar status, and preventing glycosylation-independent degradation.
INTRODUCTION
Proteins that traverse the secretory pathway fold in the endoplasmic reticulum (ER). This process is assisted by ER-resident chaperones, addition of N-linked glycans, and formation of disulfide bonds (Helenius and Aebi, 2001) . The high flux of proteins into the ER together with the complicated multidomain nature of many secreted proteins inevitably results in some fraction of proteins becoming terminally misfolded (Casagrande et al., 2000; Friedlander et al., 2000; Jensen et al., 1995; Travers et al., 2000; Ward et al., 1995) . To protect cells from the deleterious effects of such forms, the ER employs a series of mechanisms collectively referred to as ER-associated degradation (ERAD) to bring about their efficient disposal (Romisch, 2005) . In most instances, substrates are first specifically identified and then targeted for ubiquitination in preparation for their destruction in the cytosol by the proteasome (Meusser et al., 2005; Nishikawa et al., 2005; Romisch, 2005; Sayeed and Ng, 2005; Tsai et al., 2002) . Depending on the position of the misfolded lesion, the recognition step can occur either on the luminal side (ERAD-L), the cytosolic side (ERAD-C), or in the context of the ER membrane itself (ERAD-M) (Bonifacino et al., 1990; Taxis et al., 2003; Vashist and Ng, 2004) . For luminal targets, Kar2p (the major ER-localized Hsp70), has been shown to keep substrates in an ERAD-competent soluble state (Kabani et al., 2003; Nishikawa et al., 2001 ) and additionally participates in a second, less well-defined step of bringing them to the retrotranslocation machinery (Kabani et al., 2000) , which then delivers substrates across the membrane to the cytosolically located catalytic sites of the ubiquitin conjugation machinery. Following ubiquitination by membrane-associated ubiquitin ligases (e.g., Hrd1p and Doa10p in yeast) (Bays et al., 2001; Deak and Wolf, 2001; Swanson et al., 2001) , substrates are typically extracted from the membrane by the Ubx2p-recruited Cdc48p-Npl4p-Ufd1p AAA ATPase (Jarosch et al., 2002; Neuber et al., 2005; Schuberth and Buchberger, 2005; Ye et al., 2001) , which together with other ubiquitin binding proteins escorts substrates to the proteasome (Richly et al., 2005) .
Our understanding of the more downstream events in ERAD is becoming increasingly sophisticated. By comparison, detailed information is lacking on how proteins are initially selected for degradation and subsequently delivered to the ubiquitination/extraction machinery. The significance of understanding how the ER scans through the abundance of folding intermediates for terminally misfolded proteins is well illustrated by a recent study showing that the most dangerous variants of an amyloidogenic protein are those whose mutations are not so destabilizing as to trigger detection by the ERAD system (Sekijima et al., 2005) . The complexity of the recognition problem is further underscored by the risk of overvigilance, which can lead to the degradation of imperfect but potentially functional proteins, as appears to be the case for the CFTR chloride channel (Drumm et al., 1991) .
Degradation of ERAD-L substrates depends not just on substrate misfolding but also on the presence of substrate sugars (Kostova and Wolf, 2005; Spear and Ng, 2005) . The molecular basis of this dual requirement and how this information is communicated to the downstream ERAD machinery are unclear. Htm1p, a putative ER lectin required for ERAD-L, may contribute to sugar recognition (Jakob et al., 2001; Nakatsukasa et al., 2001 ). More recently, Yos9p has been identified as a conserved ER lectin with a critical role in the recognition of luminal misfolded glycoproteins (Bhamidipati et al., 2005; Buschhorn et al., 2004; Kim et al., 2005; Szathmary et al., 2005) . Furthermore, it was shown that Yos9p can associate with the prototypical ERAD-L substrate CPY* even when its sugar binding site (critical for its ERAD function) is mutated and the substrate is deglycosylated (Bhamidipati et al., 2005) . This suggests that Yos9p lies at the core of a poorly defined bipartite recognition machinery that specifically targets for retrotranslocation only those proteins that are simultaneously misfolded and have the correct sugars.
Following recognition, ERAD-L substrates are delivered to the cytosol, where they undergo ubiquitination by Hrd1p (Bays et al., 2001; Deak and Wolf, 2001 ). This membrane bound ubiquitin ligase is associated stoichiometrically with another key component of ERAD-L, Hrd3p, whose presence is required to prevent Hrd1p from undergoing self-destruction (Gardner et al., 2000; Plemper et al., 1999) . The highly conserved, large (80 kDa) nature of the Hrd3p luminal region suggests that it may play an additional role in early ERAD-L events. In fact, Hrd3p appears to have a role other than stabilizing Hrd1p (Gardner et al., 2000) . Counteracting this view, however, is the finding that simply restoring Hrd1p levels by overexpression suppresses the substrate degradation defect associated with the loss of Hrd3p (Gardner et al., 2000; Plemper et al., 1999) .
In the present study we investigate the molecular mechanism by which ERAD-L substrates are recognized and targeted for destruction. Specifically, we demonstrate that Yos9p, Hrd3p, and Kar2p form a luminal surveillance complex that recognizes misfolded substrates independent of their glycosylation status and brings them to the downstream ubiquitination/extraction machinery. Degradation, however, requires a distinct commitment step that is dependent on substrate sugars and Yos9p's sugar binding site. Finally, we show that in addition to its positive role in enhancing recruitment of bona fide ERAD-L substrates, the surveillance complex also helps eliminate basal, indiscriminate degradation which otherwise leads to cellular toxicity.
RESULTS

Yos9p Forms a Stable Complex with the Transmembrane and Cytosolic ERAD Machinery
Previous studies have shown that Yos9p associates with the misfolded, luminal ERAD substrate, CPY* (Bhamidipati et al., 2005; Kim et al., 2005; Szathmary et al., 2005) . This recognition event is likely to occur in the context of a multiprotein assembly as Yos9p is membrane associated but does not itself contain a transmembrane domain (Friedmann et al., 2002; Kim et al., 2005) . Furthermore, crosslinking experiments suggested that substrate-associated Yos9p was part of a discrete high molecular weight complex (Bhamidipati et al., 2005) . To gain insight into the composition of this complex, we used an affinity purification approach, taking advantage of a yeast strain expressing a functional 3xFLAG epitope-tagged version of Yos9p expressed from its endogenous locus ( Figure S1 ). Specifically bound proteins were isolated from detergent-solubilized microsomes and subjected to SDS-PAGE and Coomassie blue staining, thus identifying several abundantly associated polypeptides. Mass spectrometry ( Figure S2 ) indicated that the Yos9p-specific bands consisted of the following proteins: Cdc48p, Hrd3p, Kar2p, Yos9p/Ubx2p (comigrating), Hrd1p, and Emp47p ( Figure 1A ). Additionally, this complex contained Usa1p, a new ERAD component identified and characterized in the accompanying paper (Carvalho et al., 2006) . Strikingly, with the exception of Emp47p (the significance of whose association with Yos9p will be addressed elsewhere), all the Yos9p-associated proteins are known to be required for Yos9p-dependent ER-associated degradation and include luminal (Kar2p), transmembrane (Hrd1p, Hrd3p, Ubx2p, Usa1p), and fully cytosolic (Cdc48p) ERAD components (Romisch, 2005) . Thus, Yos9p is part of a stable complex that organizes a series of key components of ERAD machinery on both sides of the ER membrane.
We performed further experiments to address two specific issues regarding the integrity of the complex. First, two membrane proteins critical for ERAD-L, Der1p and Htm1p (Jakob et al., 2001; Knop et al., 1996; Nakatsukasa et al., 2001) , were not identified in our affinity purification. To exclude the possibility that these were integral components of this membrane complex whose presence was obscured for technical reasons, we repeated the purification using strains deleted for der1 or htm1. These deletions had no apparent effect on the molecular composition of the Yos9p complex (Figures 2A and 2B ). Second, we wished to explore the role of Yos9p's sugar binding pocket in complex assembly. This was motivated by our previous finding that point mutations specifically ablating this region strongly eliminated Yos9p's ability to support ERAD-L but did not interfere with substrate interaction (Bhamidipati et al., 2005) . We therefore repeated the purification with a sugar binding mutant (R200A) but detected no changes in the composition of the complex with the apparent exception of a slight decrease in Coomassie staining of the Yos9p/Ubx2p region ( Figure 2C ). However, we demonstrated that the Yos9p/Ubx2p association was not affected by directly monitoring levels of coimmunoprecipitated Ubx2p using Western blotting ( Figure 2D ). These data suggest that sugar recognition by Yos9p acts at a step downstream of substrate binding and complex assembly.
Yos9p/Kar2p/Hrd3p Form a Luminal Subcomplex Since Yos9p is a strictly luminal protein, we wished to determine the contribution of other members in the complex to Yos9p's ability to associate with Cdc48p on the cytosolic side. The multipass transmembrane protein Hrd1p was a good candidate for allowing communication between the complex components on opposing sides of the membrane (Deak and Wolf, 2001; Gardner et al., 2000) . Indeed, when we repeated the purification procedure using a hrd1 deletion strain, we observed a complete loss of Yos9p-associated Cdc48p ( Figure 1B ). In contrast, Hrd3p association remained unaffected. Together with IP-Western data confirming the presence of Hrd1p in the Yos9p immunoprecipitations ( Figure S3 ), this finding demonstrated that despite its faint appearance by Coomassie staining, Hrd1p is nonetheless absolutely required for Cdc48p's ability to associate in a complex with Yos9p.
The fact that Hrd3p has a large (80 kDa) luminal domain and exists in a 1:1 complex with the Hrd1p ubiquitin ligase (Gardner et al., 2000) suggests that Hrd3p might be responsible for anchoring Yos9p to Hrd1p/Cdc48p. In accordance with this idea, we observed a total absence of Cdc48p when we purified Yos9p from a Dhrd3 strain (Figure 1C) . Given that Kar2p and Yos9p closely migrate by SDS-PAGE, we confirmed by Western blotting that the Yos9p/Kar2p interaction is independent of the presence of Hrd3p ( Figure S4 ) and Cdc48p ( Figure 1C ). Additionally, we demonstrated that the Yos9p/Kar2p interaction is still observed even when endogenous KAR2 has been replaced by the kar2-1 peptide binding mutant ( Figure 1D ) (Kabani et al., 2003) . This suggests that Kar2p's association with Yos9p is not solely mediated through Kar2p's ability to interact with unfolded proteins.
We further explored the Yos9p/Hrd3p interaction using truncations of Hrd3p. Hrd3p comprises a luminal region, consisting of domains A (residues 1-390) and B (residues 390-767), that is attached to a transmembrane anchor and a cytosolic tail (residues 767-833) (Gardner et al., 2000 ; Figure 3A ). To investigate which of these regions was responsible for the observed interaction with Yos9p, we generated strains expressing from the endogenous locus C-terminally tagged variants of Hrd3p and tested their ability to coimmunoprecipitate Yos9p. As shown in Figure 3B , both full-length and A-B (1-767) Hrd3p (but not the A domain alone) were able to pull down Yos9p, indicating that the B domain is required for Yos9p binding while the transmembrane anchor and the cytosolic tail are dispensable. We further find that strong overexpression of either Yos9p or Hrd3p alone results in only a minor enhancement in the amount of Hrd3p pulled down with Yos9p ( Figure 3C ). However, concomitant overexpression of both proteins resulted in a synergistic 20-fold increase in Yos9p/Hrd3p complex formation ( Figure 3C ). Moreover, this interaction persisted even following deglycosylation Microsomes were prepared from late mid-log phase cells expressing genomic copies of either untagged Yos9p (A) or Yos9-FLAG (A-C) in wild-type, Dhrd1, or Dhrd3 strain backgrounds as shown. The microsomes were solubilized with Triton X-100 and affinity purified using anti-FLAG beads. Immunoprecipitates were eluted with 33FLAG peptide and resolved by SDS-PAGE followed by Coomassie blue staining. The identity of bands in (A) was determined by mass spectrometry. * denotes the position of missing bands. Molecular weights are labeled according to a prestained protein ladder. (D) As indicated, wild-type or kar2-1 cells were transformed with empty vector or pRS315-Yos9-FLAG. Prior to harvesting, cells were shifted to the nonpermissive kar2-1 temperature (37 C) for 1 hr. Subsequently, total cell lysates were solubilized with 1% Triton X-100, cleared, and immunoprecipitated with anti-FLAG resin. Bound proteins were eluted by boiling in SDS loading buffer and along with total cell lysates were resolved by SDS-PAGE followed by Western blot analysis with the indicated antibodies.
of both proteins by EndoH ( Figure S5 ). Thus the observed Yos9p interaction with Hrd3p is sugar independent and unlikely to be bridged by other dedicated ERAD components. Collectively, these findings lead us to propose the following model for the molecular organization of the complex ( Figure 3D ). Yos9p, Kar2p, and the luminal domain of Hrd3p form a complex, which is anchored to the transmembrane Hrd1p ubiquitin ligase (Gardner et al., 2000) . In turn, Hrd1p, in a manner that depends on its ligase activity, recruits Ubx2p-tethered Cdc48p (Gauss et al., 2006; Neuber et al., 2005; Schuberth and Buchberger, 2005) , a cytosolic protein shown to be required for the extraction of substrates from the ER membrane (Jarosch et al., 2002; Ye et al., 2001 ). The transmembrane proteins Der1p and Htm1p are central players in ERAD, but our results establish that they are not required for the integrity of the Yos9p complex described here.
Yos9p and Hrd3p Can Recruit Misfolded Proteins Independently of Each Other
We next wanted to explore how ERAD-L substrates are recruited to the Hrd1p ubiquitin ligase complex. First we tested whether the Yos9p-substrate interaction is dependent on Hrd3p. As previously reported, Yos9p coimmunoprecipitated with the prototypical ERAD-L substrate CPY*, and this interaction did not depend on substrate sugars, either alone or in combination with the R200A Yos9p lectin mutant ( Figures 4A and 4B ), but was specific for the misfolded form (Bhamidipati et al., 2005; Kim et al., 2005; Szathmary et al., 2005;  Figure S6 ). Importantly, these interactions persisted even in strains lacking HRD3, suggesting that they were being mediated directly by Yos9p and/or Kar2p.
To investigate the simple model that Hrd3p is acting as a passive scaffold for bridging the Yos9p/Kar2p/substrate complex with the downstream ERAD machinery, we asked whether Yos9p was required for the ability of substrate to be coimmunoprecipitated with Hrd3p Gauss et al., 2006) . We initially found that various N-or C-terminally tagged versions of full-length Hrd3p either gave very weak Western signals or were nonfunctional (data not shown). However, as demonstrated in the case of HMG-CoA Reductase 2 degradation (Gardner et al., 2000) , Hrd3 1-767 -MYC efficiently supported CPY* degradation when tagged at the C terminus ( Figure S7 ) and robustly interacted with Yos9p ( Figures 3B and 3C ). As expected, Microsomes were made from wild-type, Dder1, or Dhtm1 log phase cells expressing genomic Yos9-FLAG (A and B) or Yos9-FLAG and R200AYos9-FLAG from a plasmid (C) as indicated. Microsomes were solubilized and Yos9p was immunoprecipitated as described in Figure 1A . Note: Usa1p comigrates with Hrd3p. We did not explicitly test for the presence of Usa1p in the various deletion strains. (D) Wild-type or UBX2-TAP::HISMX6 cells were transformed with either an empty vector, pRS315-Yos9-FLAG, or pRS315-R200AYos9-FLAG as indicated and subjected to immunoprecipitation as described in Figure 1D . Anti-CBP was used to visualize the TAP fusion protein while anti-Sec61p served as a negative control.
based on its association with Yos9p, Hrd3p was able to interact with both CPY* as well as with an unglycosylated variant of CPY* (CPY*0000) that is not subject to ERAD-L ( Figure 5A ) (Kostova and Wolf, 2005; Spear and Ng, 2005) . Surprisingly, we still observed coimmunoprecipitation of Hrd3p with CPY* and CPY*0000 in a strain deleted for YOS9 ( Figure 5A ). This interaction is likely to be direct because it was observed even in the absence of Der1p, (B) A 13MYC tag was inserted at the HRD3 locus following amino acids 390, 767, or 833 in a strain expressing Yos9 genomic FLAG. The cells were immunoprecipitated with anti-MYC as described in Figure 1D . (C) Strains expressing endogenous or overexpressed (symbolized with [ indicating TDH3 promoter driven expression) tagged versions of Yos9p and Hrd3 1-767 p were mated as shown and subjected to immunoprecipitation as described in Figure 1D . The numbers in parentheses indicate the levels of each protein relative to the control strain expressing endogenous levels of both proteins.
(D) Proposed model of how Yos9p associates with other ERAD components in the ER membrane and cytosol. Hrd1p anchors at least a portion of the Yos9p/Kar2p/Hrd3p surveillance complex to the ER membrane and interacts with Ubx2p which recruits Cdc48p to the membrane complex (the dependence of Cdc48p recruitment on Hrd1p's ubiquitin ligase activity is not depicted in the figure). Der1p and Htm1p may associate but are not important for the integrity of the complex. Ubc7p and its membrane anchor Cue1p are necessary for the ubiquitination of substrates by Hrd1p. Usa1p not pictured. Htm1p, and Hrd1p (which is responsible for anchoring the Hrd3p luminal domain) ( Figures 5A and 5B) . Furthermore, we observed that overexpression of Hrd3p leads to a proportional increase in the amount of Hrd3p-CPY* complex recovered by immunoprecipitation ( Figure 5C ). Several lines of evidence argue for the validity and specificity of this interaction. First, the observed association between Hrd3p and substrate is unlikely to be an artifact of inadequate membrane disruption as we solubilized lysates using a large excess of Triton X-100, a strong nonionic detergent, and we observed no interaction with the abundant ER membrane protein Sec61p (Figures 5A and 5B) . Second, this interaction is not due to the formation of a large substrate aggregate that nonspecifically incorporates other proteins because it remains in the supernatant even after clearing the solubilized lysates at 100,000 3 g for 45 min. Finally, the interaction is highly specific for the misfolded form of carboxypeptidase Y since we could vastly increase the amount of native CPY in the ER by deleting the gene for its ER export receptor, Erv29p (Belden and Barlowe, 2001 ), without observing a significant interaction with Hrd3p (Figure 5D ). We therefore conclude that Yos9p/Kar2p and Hrd3p independently recognize misfolded ER luminal proteins.
Substrate Engagement with the Multiprotein Hrd1p Ligase Complex Is Sugar Independent
The observation that the Yos9p lectin mutant (R200A) interacted with both substrates (Figure 4) and downstream ERAD components ( Figure 2D ) suggests that recognition and commitment to degradation are mechanistically separable events. To test this idea further, we made use of a recently identified ERAD-L component (Carvalho et al., 2006) , Usa1p. As expected based on Usa1p's association with Yos9p and Hrd3p (Carvalho et al., 2006 ; Figure S2 ), we show that Usa1p can be coimmunoprecipitated with CPY* in a Hrd3p-dependent manner (Figure 6 ). Notably, despite the fact that CPY*0000 cannot be degraded by the ERAD-L system, it nonetheless is part of a multiprotein complex including Usa1p (Figure 6 ; Figure S8 ). These data suggest that substrate recruitment to the ERAD core machinery can be mechanistically distinguished from a subsequent commitment to degradation. It is this commitment step in the ERAD process that confers dependence on substrate glycosylation and Yos9p's sugar binding site.
Hrd1p Gating by Yos9p/Hrd3p Prevents Promiscuous Degradation
Our finding that Hrd3p plays a key role in bringing Yos9p to the ubiquitin degradation machinery and independently recognizing substrates seems at odds with previously published reports indicating that the strong substrate degradation defect in a Dhrd3 mutant is bypassed by overexpression of Hrd1p (Gardner et al., 2000; Plemper et al., 1999) . To explore this apparent discrepancy, we first recapitulated the phenomenon by placing Hrd1p under the control of a strong (TDH3) promoter (Gardner et al., 2000) and confirmed that CPY* stabilization in a hrd3 delete is in fact partially alleviated by overexpression of Hrd1p ( Figure 7A ). Next, we examined the contribution of Yos9p to substrate recognition in the context of Hrd1p overexpression and found that deleting YOS9 had no effect on Hrd1p's ability to stimulate CPY* degradation ( Figure 7A ). This is in marked contrast to the strong CPY* stabilizing effect of deleting YOS9 in strains with regulated Hrd1p function (Bhamidipati et al., 2005; Buschhorn et al., 2004; Kim et al., 2005; Szathmary et al., 2005;  Figure S1 ). In light of the above suggestion that the sugar binding site of Yos9p acts at a commitment step that is downstream of substrate recruitment to the complex, we wanted to reinvestigate the requirement for glycosylation in this Hrd1p overexpression bypass regime. We first confirmed that the removal of substrate sugars leads to a dramatic stabilization of CPY*, comparable to that observed when HRD3 or YOS9 are deleted. Strikingly, under conditions of Hrd1p overexpression in a hrd3 deletion mutant, we saw significant degradation of CPY*0000, such that its degradation was now similar to that of CPY* ( Figure 7B ). This promiscuous destruction of an otherwise stable protein could account for our observation that overexpression of Hrd1p causes S288C yeast strains to grow at a reduced rate (Figure 7C) . In order to confirm that this effect was indeed due A) Dyos9Dder1HRD3 or Dyos9Dder1Dhrd3 cells were transformed with pRS315-Yos9-FLAG, together with an empty vector, or one expressing CPY* or CPY*0000 as indicated. Following spheroplasting and lysis by bead beating, crude membranes were solubilized with 1% Triton-X100 and subjected to immunoprecipitation with anti-HA essentially as described in Figure 1D . (B) Dyos9Dder1HRD3 or Dyos9Dder1Dhrd3 cells were transformed with pRS315-R200AYos9-FLAG together with an empty vector or a vector expressing CPY*0000, as indicated. Spheroplasting and immunoprecipitation were performed as described in Figure 4A .
to deregulated ubiquitin ligase activity, we deleted CUE1, the ER membrane anchor for the Ubc7p E2 enzyme (Biederer et al., 1997) , and observed suppression of both the promiscuous degradation ( Figures 7D and S9 ) and the growth phenotype ( Figure 7C ). Taken together, these data suggest that uncensored Hrd1p activity caused by the disruption of the Yos9p/Hrd3p gating mechanism results in the destruction of proteins normally spared by the rules and restrictions of ERAD-L recognition, thus leading to impaired cellular viability. Figure 1D. (B) The indicated strains expressing Hrd3 1-767 -MYC were transformed with an empty vector or a vector expressing CPY* or CPY*0000 as shown and subjected to immunoprecipitation as in Figure 1D . (C) Strains expressing endogenous or overexpressing tagged versions of Hrd3 1-767 -MYC were transformed with empty vector or a vector expressing CPY* and subjected to immunoprecipitation as in Figure 1D . Upward arrow indicates TDH3 promoter-driven expression. (D) Dder1Derv29YOS9 or Dder1Derv29Dyos9 cells expressing Hrd3 1-767 -MYC were transformed with an empty vector or a vector expressing CPY* or wild-type CPY, as indicated, and subjected to immunoprecipitation as described in Figure 1D .
DISCUSSION
The ER must specifically identify terminally misfolded proteins in an environment dominated by structurally similar on-pathway folding intermediates. Compounding the complexity of this substrate selection problem is the fact that surveillance has to be enforced on three topological fronts (luminal, membrane, and cytosolic). Accordingly, the ER-associated degradation system comprises multiple converging pathways (Romisch, 2005; Sayeed and Ng, 2005) . At the top of this arborized organization is a multiplicity of recognition factors in charge of initiating substrates down increasingly narrow paths that culminate in their degradation by the cytosolic proteasome machinery. While there have been substantial advances in understanding how in mammalian cells viruses target for destruction specific folded endogenous proteins such as class I MHC heavy chains Ploegh, 2004, 2005; Ye et al., 2004 Ye et al., , 2005 , it remains poorly understood how recognition of terminally misfolded proteins is accomplished and coupled to shared downstream ERAD components.
In the present study we address this substrate selectivity issue for ERAD-L, a major conserved pathway responsible for the degradation of luminal misfolded glycoproteins (Vashist and Ng, 2004) . In order to focus on a single, coherent branch of the ERAD system, we started with a top-down approach centered on Yos9p, a luminal lectin thought to act early in the pathway. This led to the identification of a Yos9p/Kar2p/Hrd3p surveillance complex that brings ERAD-L substrates into contact with the downstream Hrd1p ubiquitin ligase and the accompanying Ubx2p-recruited Cdc48p. Remarkably, both Yos9p/ Kar2p and Hrd3p can individually recognize the Wild-type or Dhrd3 cells expressing C-terminally tagged Usa1-MYC were transformed with an empty vector or a vector expressing CPY* or CPY*0000, as indicated, and subjected to immunoprecipitation as in Figure 1D . prototypical ERAD-L substrate CPY* in a manner that depends on the folding status but not the glycosylation state of the substrate. The above recruitment step tethers putative substrates to the ubiquitination/extraction machinery on the other side of the membrane by way of the Hrd3p/ Hrd1p interaction. Substrate degradation requires a distinct commitment step that is dependent on both the substrate sugars and an intact Yos9p sugar binding site. The mechanism by which this commitment step allows substrates to proceed down the ERAD-L pathway remains unclear. One intriguing possibility is that Yos9p, possibly together with Htm1p, queries the sugar status of the substrate and, for glycoproteins judged to be legitimate ERAD substrates, allows for the participation of Der1p in the subsequent retrotranslocation step. Interestingly, recent studies suggest physical interaction between glycosylated ERAD substrates and Der1p/Derlin (Gauss et al., 2006; Oda et al., 2006) , arguing for the possible existence of distinct substrate recognition events that are not mediated by the Yos9p/Hrd3p recruitment complex. It remains to be established how this multiplicity of recognition events are coordinated to bring about the substrate commitment to degradation.
Why has such a baroque mechanism evolved for selection of ERAD substrates? While the exact structural and kinetic features of misfolded proteins that lead to their recognition by the ERAD machinery are not well delineated, it now appears that recognition does not simply involve assessment of a protein's thermodynamic stability (Sekijima et al., 2005) . The cooperation of two interacting complexes (Hrd3p and Yos9p/Kar2p), each of which are individually capable of binding misfolded forms, could allow for a more sophisticated probing of the biophysical properties of nonnative proteins. For example, dual binding would be expected to favor recognition of substrates with extended or multiple nonnative epitopes. On a more speculative note, the use of a two-step process (i.e., recruitment and commitment) could allow for enhanced specificity by a kinetic proofreading mechanism, especially if the two steps are separated by an irreversible process (Hopfield, 1974) such as, for example, sugar trimming (Hirao et al., 2006) or ATP hydrolysis by Kar2p. Additionally, there may be proofreading steps upstream and/or downstream of the Yos9p/ Hrd3p recruitment process studied here.
More concretely, we demonstrate that the Yos9p/ Kar2p/Hrd3p surveillance complex promotes specificity by acting as a gatekeeper of the Hrd1p ubiquitin ligase, ensuring that only legitimate substrates are degraded. It acts to enhance the delivery and degradation of bona fide ERAD-L substrates while on the other hand repressing indiscriminate degradation of ER proteins. The significance of suppressing the basal degradation activity is illustrated by the slow growth phenotype that results when upstream recognition is bypassed in a hrd3 deletion mutant overexpressing Hrd1p. Such deleterious effects are elegantly avoided in wild-type cells by the fact that Hrd1p has a built in autodestruction mechanism when it is not complexed with Hrd3p (Gardner et al., 2000; Plemper et al., 1999) . This reduced specificity for retrotranslocation caused by Hrd1p overexpression is reminiscent of bacterial translocon mutants that are able to promiscuously export polypeptides in a signal sequence-independent manner (Flower et al., 1994) .
More practically, manipulating the specificity of the ERAD system could yield an attractive therapeutic strategy (e.g., for supporting degradation of a mutant allele). However, such efforts are hampered by the broad protective role of the ERAD systems and the fact that many ERAD components are shared with other biological processes (Adams, 2002) . Because the ERAD-L surveillance complex is dedicated to channeling only a subset of ERAD substrates for degradation, a better understanding of this targeting step may aid in the development of future pharmacological approaches with enhanced selectivity for specific disease processes.
EXPERIMENTAL PROCEDURES
Plasmid and Strain Construction
See Supplemental Experimental Procedures.
Antibodies
Sec61p and Kar2p antisera were a gift from Randy Schekman (University of California, Berkeley) and Peter Walter (University of California, San Francisco). HA epitope was detected using 12CA5 monoclonal antibody (Roche). In Figure 4B , HA epitope was detected using polyclonal Y11 HA-probe (Santa Cruz Biotechnology). Anti-CBP TEV-N Peptide, anti-FLAG M2 monoclonal antibody, anti-hexokinase, and anti-CPY mouse monoclonal 10A5 were purchased from Bethyl Laboratories Inc, Sigma, US Biologicals, and Molecular Probes, Inc, respectively. MYC tag was detected by 9E10 monoclonal antibody (Roche). Secondary Antibodies labeled with IR800 dye and Alexa Fluor 680 were purchased from Rockland Immunochemicals and Molecular Probes, Inc, respectively. Native Immunoprecipitations-Large Scale ER derived microsomes were prepared from late mid-log phase yeast cells (2800 OD 600 units) grown in YPD (The strains in Figure 2C were grown in selective media) and harvested by centrifugation. The cells were washed with water, resuspended in 50 ml of 100 mM Tris-HCL [9.4] buffer containing 10 mm DTT, and incubated for 5 min at room temperature. The cells were pelleted and resuspended in 20 ml lyticase buffer (50 mM Tris-HCL [7.8], 1 M sorbitol, 5 mM bMe, 100 mM NaCl). Three milliliters of lyticase made using a plasmid that was a gift from Randy Schekman (University of California, Berkeley) was added and the cells were incubated at 30 degrees until at least 80% spheroplasting efficiency was achieved. The spheroplasts were pelleted at 3000 g for 4 min at 4 C and washed with lyticase buffer before being resuspended in 25 ml of cold lysis buffer (25 mM HEPES-KOH [6.8], 10 mM NaCl, 200 mM sorbitol, 1 mM MgCl 2 , 1 mM CaCl 2 , protease inhibitors). The cells were then incubated for 15 min on ice and lysed by douncing. The lysates were cleared twice at 1000 g for 8 min and the resulting supernatant was subjected to a high-speed spin at 50,000 g. The microsome pellet was washed once before being solubilized in 5 ml HEPES IP buffer (50 mM HEPES-KOH [6.8], 150 mM KOAc, 2 mM MgOAc, 1 mM CaCl 2 , protease inhibitors) plus 1% Triton X-100 for 1 hr at 4 C. The solubilized microsomes were spun for 22 min at 50,000 g. One hundred and twenty to one hundred and fifty microliters pre-equilibrated anti-FLAG resin (Sigma) was added to the supernatant and incubated at 4 C for 3 hr. The immunoprecipates were washed with 4 3 5 ml of IP buffer plus 1% Triton X-100. The bound protein was eluted with 60-75 ul of 33 FLAG peptide (Sigma) resuspended in IP buffer plus 1% Triton X-100 to a final concentration of 1 mg/ml and mixing on ice for 30 min. SDS loading buffer was added to half of the eluate and run on 4%-12% SDS-PAGE gels followed by staining overnight with Colloidal Blue stain (Invitrogen), referred to as Coomassie blue in the text. For Figure 1A , protein bands were excised from the gel and analyzed by Arnie Falick, David King, and Sharleen Zhou at the Howard Hughes Medical Institute Mass Spectrometry Laboratory, University of California, Berkeley. Gel slices were trypsinized (Promega) and mass spectra were acquired on a Bruker Reflex III MALDI-TOF mass spectrometer. Proteins were identified by searching NCBInr database using MS-Fit program on Protein Prospector (UCSF, http://prospector.ucsf.edu) (Jimenez et al., 1998) .
Native Immunoprecitations-Small Scale Yeast cells (40-80 OD 600 units depending on experiment) were grown to late mid-log phase in selective media. After being washed in water, cells were lysed by bead beating in 0.5 ml HEPES IP buffer containing 0.1% Triton X-100. The detergent concentration was then raised to 1% in a final volume of 1 ml. The crude lysate was solubilized for 30 min at 4 C and then spun at 100,000 g for 45 min (except for Figure 3B , which was done at 21,000 g for 10 min). The cleared supernatant was added to 25 ml of equilibrated affinity resin and incubated at 4 C for 1-3 hr.
The immunoprecipitates were washed 4 3 1 ml with HEPES IP buffer plus 1% Triton X-100. Bound material was eluted by boiling in SDS loading buffer and subjected to SDS-PAGE followed by Western blotting and detection using the LI-COR Odyssey system. An alternative lysis protocol was used for Figures 4A, 4B , and S6. Here the cells were first spheroplasted (Bhamidipati et al., 2005) before being lysed by bead beating in HEPES IP buffer containing 0.2 M sorbitol (without detergent). The lysate was spun at 21,000 g for 10 min and the resulting crude membrane fraction solubilized in 1 ml of HEPES IP buffer plus 1% Triton X-100 for 30 min at 4 C. The resulting solubilized membranes were cleared and processed exactly as indicated above.
EndoH treatment was performed as described (Bhamidipati et al., 2005) .
Cycloheximide Chase Degradation Assay
Cycloheximide chase degradation assays were performed as previously described (Bhamidipati et al., 2005) . In brief, log phase cells were treated with 200 mg/ml cycloheximide to terminate protein synthesis. Time points were aliquoted into cold YEP (to facilitate subsequent pelleting) and 10 mM NaF/NaN 3 followed by pelleting and flash freezing in liquid nitrogen. The cells were then lysed with boiling SDS loading buffer, subjected to SDS-PAGE, and immunoblotted as described above. Bands were visualized using the LI-COR Odyssey system (which allows for two color detection) and subsequently quantitated with LI-COR Odyssey software. Following normalization to the hexokinase loading control, the values were plotted as averages ± standard deviation of four measurements (two independent experiments done in duplicate) with time point 0 set to 100%.
Supplemental Data
Supplemental Data include nine figures and experimental procedures and can be found with this article online at http://www.cell.com/cgi/ content/full/126/2/349/DC1/.
